I am a physician scientist who received clinical training in Endocrinology in the major University of Barcelona hospital, and in Washington University. I received research training in the same institutions as well as in Massachusetts General Hospital. In 1998 I moved to Barcelona as attending Clinical Endocrinologist, and had the opportunity to establish a diabetes research lab. Since then, my team has combined genetic model systems and advanced genomic technologies to address key questions for human diabetes, such as the molecular mechanisms of type 2 diabetes, and the development of new therapies for monogenic diabetes.I moved to Imperial College in October 2012, and became Head of Epigenomics and Disease Section. Since then I have procured funding from several sources, including a Wellcome Trust Senior Investigator Award, an MRC programme, and a grant from the NIH. I hold a secondary appointment in Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, where I supervise the continuation of my previous lab that is still funded by a Spanish diabetes network and supports my research activities in Imperial College London.